3Potter PD,Shields CL,Shields JA,et al. Use of the hydroxyapatite ocular implant in the pediatric population.Arch Ophthalmol, 1994,112(2) : 208.
4Gupta M,Puri P,Rennie IG.Use of bovine pericardium as a wrapping material for hydroxyapatite orbital implants[J].Br J Ophthalmol 2002;86:288-289.
5Shield CL,Shields JA,Eagle RC,De Potter P.Histopathologic evidence of fibrovascular in growth four weeks after placement of the hydroxyapatite orbital implant[J].Am J Ophthalmol 1991;111:363-366.
6Liao SL,Kao SCS,Tseng JHS,Lin LL-K.Surgical coverage of exposed hydroxyapatite implant with retroauricular myoperiosteal graft[J].Br J Ophthalmol 2005;89(1):92-95.
7Inkster CF,Ng SG,Leather B.Primary banked scleral patch graft in the prevention of exposure of hydroxyapatite orbital implants[J].Ophthalmology 2002;109(2):389-392.
8Devoto MH,Zaffaroni MC.Orbital myiasis in a patient with a chronically exposed hydroxyapatite implant[J].Ophthal Plast Reconstr Surg 2004;20:395-396.
9Seiff SR,Chang JS Jr,Hurt MH,Khayam-Bashi H.Polymerase chain reaction identification of human immunodeficiency virus-1 in preserved human sclera[J].Am J Ophthalmol 1994;118(4):528-530.
10Kao LY.Polytetrafluoroethylene as a wrapping material for a hydroxyapatite orbital implant[J].Ophthal Plast Reconstr Surg 2000;16(4):286-288.
